Trial · NCT07889141
Integrated Core Stability Exercises and Yoga Program on Premenstrual Syndrome
NCT07889141, Not applicable, Not yet recruiting, Mansoura University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Integrated Core Stability Exercises and Yoga Program on Premenstrual Syndrome. Trials, record NCT07889141. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07889141
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Integrated Core Stability Exercises and Yoga Program on Premenstrual Syndrome
- NCT number
- NCT07889141
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 92 participants, estimated
- Lead sponsor
- Mansoura University
- Conditions
- Premenstrual Syndrome
- Interventions
- exercises program
- First posted
- 2026-10-22
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Tool I: A Structured Interview Questionnaire | At baseline and during the week preceding menstruation at the first and second menstrual cycles following the intervention, corresponding to the 4-week post-intervention assessment and the 8-week follow-up assessment, respectively. | This tool will be developed by the researcher after reviewing the literature review . It will consist of two parts: Part I: General characteristics of nursing students such as: (age, weight, height, educational class, residence and practicing exercise before the program.…etc). Part II: Menstrual history of nursing students: It will be used to assess the basic characteristics of menstrual cycle for each student such as: menarche age, frequency of menstrual cycle, duration of menstrual flow, amount of menstrual blood loss, number of pads per day, first experience of PMS, frequency of PMS, onset of pain at each period, total duration of pain in hours, and measures taken during each cycle to get relief from pain…etc). |
| Primary | Tool (II): Premenstrual Symptoms Screening Tool (PSST) | At baseline, 4 weeks after the intervention, and 8 weeks after the intervention. | This tool is a 19-item questionnaire that uses the categorical Standardized Diagnostic (DSM) criteria associated with premenstrual symptoms (PMS) as a symptom rating scale, with degrees of severity. It is divided into two domains. The first domain includes 14 premenstrual symptoms such as; depression, anxiety, irritability, mood swings, decreased interest in activities, difficulties concentrating, exhaustion, eating changes, sleep disruptions, feeling overwhelmed, and physical symptoms. The PSST is interpreted using standardized diagnostic criteria rather than a total score. Each PSST item is rated on a four-point Likert-like scale (i.e., 0 'not at all', 1 'mild', 2 'moderate', and 3 'severe'). For the assessment of moderate to severe P |
| Primary | Tool (III): Visual Analogue Scale (VAS) | At baseline and during the week preceding menstruation at the first and second menstrual cycles following the intervention, corresponding to the 4-week post-intervention assessment and the 8-week follow-up assessment, respectively. | Scores are based on self-reported pain measurements that are recorded with a single hand-written mark placed at one point along a 10-cm line that represents a continuum between the two ends of the scale, they will be instructed to indicate their preference by pointing to the corresponding number on the line or by observing the expression of pain on their face, with "no pain" on the left end (0 cm) and the "worst pain" on the right end (10 cm).The Visual Analogue Scale is divided into three main sections; the first section graded from 1-3 cm, which represents mild pain; the second section rated from 4-7 cm, which represents moderate pain; and the third section graded from 8-10 cm |
| Primary | Tool (IV): Short Form-36 Health Survey (SF-36): | At baseline and during the week preceding menstruation at the first and second menstrual cycles following the intervention, corresponding to the 4-week post-intervention assessment and the 8-week follow-up assessment, respectively. | The 36-Item Short Form Health Survey (SF-36), a standardized, self-administered generic questionnaire designed to assess perceived physical and mental health. This tool is consisted of 36 items that cover eight health domains including: physical functioning (10 items), role limitations due to physical health (4 items), bodily pain (2 items), general health perceptions (5 items), vitality (4 items), social functioning (2 items), role limitations due to emotional problems (3 items), and mental health (5 items). The SF-36 will be scored according to the standard scoring manual. Each item will be coded, recoded when necessary, and transformed into a 0-100 scale. Scores will be calculated separately for the eight health domains: For each domain, item scores will be averaged after transformation, yielding a score ranging from 0 to 100. Higher scores indicate better health-related quality of life, |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07889141
GET https://conductscience.org/api/trials/v1/NCT07889141/registered